Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03287349 · ClinicalTrials.gov registry record
Genomic Assessment of Patients With Severe Radiation Reactions
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 3
- Enrollment target
NCT03287349: Completed study, sponsored by Mayo Clinic.
NCT03287349 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03287349 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw.
Primary Outcome
Investigate genes potentially responsible for severe radiation reactions by getting blood draws.
Interventions
- OTHER Blood draw
- OTHER Photograph
- DIAGNOSTIC_TEST Autoimmune testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2023-01-04 |
What the finished NCT03287349 record still lists
NCT03287349 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT03287349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03287349 about?
NCT03287349 is a clinical study titled "Genomic Assessment of Patients With Severe Radiation Reactions". Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw.
What is the current status of trial NCT03287349?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2017-05-10. Estimated completion is 2023-01-04.
What interventions are being tested in trial NCT03287349?
The interventions under investigation include: Blood draw (OTHER), Photograph (OTHER), Autoimmune testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03287349?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI